A Portuguese biomedical foundation pairing neuroscience and cancer research with clinical care, aiming to carry laboratory discovery to patients.
Champalimaud Foundation
Released February 23, 2025
Chromatin signal prediction that fuses reference DNA with per-nucleotide ATAC-seq, calling CTCF and histone marks in any cellular context.